Zobrazeno 1 - 10
of 89
pro vyhledávání: '"S O Salugina"'
Publikováno v:
Терапевтический архив, Vol 89, Iss 11, Pp 111-115 (2017)
The paper reviews the publications dealing with Schnitzler syndrome, a rare autoinflammatory disease, and describes the authors’ own clinical observation. It describes the first Russian experience in successfully using the interleukin-1 inhibitor c
Externí odkaz:
https://doaj.org/article/66dcfa80b8d64868983212ce563efaa5
Publikováno v:
Терапевтический архив, Vol 88, Iss 6, Pp 58-64 (2016)
Aim. To determine the possibility of using the serum proinflammatory calcium-binding protein, or calgranulin C (S100A12), to assess activity and therapeutic efficiency in patients with periodic disease (PD) and other familial periodic fevers (FPFs).
Externí odkaz:
https://doaj.org/article/3f68db3201fe477db2d6e9b2996fa2f3
Publikováno v:
Современная ревматология, Vol 0, Iss 1, Pp 24-30 (2013)
The paper deals with the most common classical autoinflammatory disease familial Mediterra-nean fever (FMF)/periodic disease. This is a monogenic hereditary disease caused by mutations with an autosomal recessive pattern of inheritance. The most comm
Externí odkaz:
https://doaj.org/article/7606e633247d420f8e81f60f75e845df
Publikováno v:
Современная ревматология, Vol 6, Iss 3, Pp 60-65 (2012)
Externí odkaz:
https://doaj.org/article/3aa64dc5111c4d1cafd549f98df61f5b
Publikováno v:
Современная ревматология, Vol 6, Iss 2, Pp 49-59 (2012)
Externí odkaz:
https://doaj.org/article/25f46940648c4139b49afbc838288d9f
Publikováno v:
Научно-практическая ревматология, Vol 49, Iss 1, Pp 78-93 (2011)
The mechanisms of action of currently used genetic engineering biological agents (GEBAs) include inhibition of cytokines, interleukins, and T cells and depletion of B cells. GEBAs were originally accessible mainly for the treatment of refractory juve
Externí odkaz:
https://doaj.org/article/e8599cf3dc234bc2b75245820a242de3
Publikováno v:
Терапевтический архив, Vol 82, Iss 5, Pp 22-29 (2010)
Aim. To assess the course and outcomes, functional and social status in long ill patients with juvenile arthritis (JA). Subjects and methods. The study included 213 patients aged 16 to 60 years (mean age 23.9 ± 6.5 years) with JA with its duration o
Externí odkaz:
https://doaj.org/article/5c79b07eb24e4e2aa51ee311ca2d200a
Publikováno v:
Научно-практическая ревматология, Vol 47, Iss 6, Pp 71-77 (2009)
Objective. To study clinical and laboratory manifestations of different variants of juvenile arthritis (JA) at the disease onset and during prospective two-year follow up. Material and methods. The study was performed as a part of Institute of Rheuma
Externí odkaz:
https://doaj.org/article/45481fb9f26c4d57b02b1afaef9ef72d
Autor:
S O Salugina, E S Fedorov, E N Aleksandrova, A A Novikov, M V Cherkasova, A A Baranov, Yu A Valogina
Publikováno v:
Современная ревматология, Vol 3, Iss 2, Pp 24-28 (2009)
Objective: to estimate the concentration of anti-cyclic citrullinated peptide antibodies (CCPA), the frequency of their increase, and their diagnostic value in children with early juvenile arthritis (JA). Subjects and methods. Sera from 80 patients (
Externí odkaz:
https://doaj.org/article/02540af0208847129e05c0ee7e1e9444
Publikováno v:
Научно-практическая ревматология, Vol 47, Iss 3, Pp 74-89 (2009)
Хронические артриты у детей являются важной проблемой современной педиатрии в силу того, что эти тяжелые заболевания существенно наруш
Externí odkaz:
https://doaj.org/article/b695ae4cd7c14e9e8f55bd1416711023